These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3309490)

  • 1. Recent progress in the research of Alzheimer's disease.
    Riekkinen PJ; Laulumaa V; Sirviö J; Soininen H; Helkala EL
    Med Biol; 1987; 65(2-3):83-8. PubMed ID: 3309490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of attentional dysfunction in Alzheimer's disease: theoretical and practical implications.
    Foldi NS; Lobosco JJ; Schaefer LA
    Semin Speech Lang; 2002 May; 23(2):139-50. PubMed ID: 11951174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline.
    Gibbs RB; Aggarwal P
    Horm Behav; 1998 Oct; 34(2):98-111. PubMed ID: 9799621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampus as comparator: role of the two input and two output systems of the hippocampus in selection and registration of information.
    Vinogradova OS
    Hippocampus; 2001; 11(5):578-98. PubMed ID: 11732710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hippocampal atrophy and disconnection in incipient and mild Alzheimer's disease.
    deToledo-Morrell L; Stoub TR; Wang C
    Prog Brain Res; 2007; 163():741-53. PubMed ID: 17765748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory.
    Wilson WL; Munn C; Ross RC; Harding JW; Wright JW
    Brain Res; 2009 May; 1272():25-31. PubMed ID: 19328191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer disease, attention, and the cholinergic system.
    Lawrence AD; Sahakian BJ
    Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():43-9. PubMed ID: 8534423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Goekoop R; Scheltens P; Barkhof F; Rombouts SA
    Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.
    Mufson EJ; Counts SE; Perez SE; Binder L
    Neuropeptides; 2005 Jun; 39(3):233-7. PubMed ID: 15893372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal studies of brain acetylcholine and memory.
    Beninger RJ; Wirsching BA; Jhamandas K; Boegman RJ
    Arch Gerontol Geriatr Suppl; 1989; 1():71-89. PubMed ID: 2569316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prepulse inhibition in patients with Alzheimer's disease.
    Hejl AM; Glenthøj B; Mackeprang T; Hemmingsen R; Waldemar G
    Neurobiol Aging; 2004 Sep; 25(8):1045-50. PubMed ID: 15212829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.
    Peters F; Collette F; Degueldre C; Sterpenich V; Majerus S; Salmon E
    Brain; 2009 Jul; 132(Pt 7):1833-46. PubMed ID: 19433442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
    Luques L; Shoham S; Weinstock M
    Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
    Giovagnoli AR; Erbetta A; Reati F; Bugiani O
    Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and acetylcholine receptors.
    Kihara T; Shimohama S
    Acta Neurobiol Exp (Wars); 2004; 64(1):99-105. PubMed ID: 15190684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implicit memory and Alzheimer's disease neuropathology.
    Fleischman DA; Wilson RS; Gabrieli JD; Schneider JA; Bienias JL; Bennett DA
    Brain; 2005 Sep; 128(Pt 9):2006-15. PubMed ID: 15975947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease pathogenesis and therapeutic interventions.
    Parihar MS; Hemnani T
    J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.